16 results
424B4
ACLX
Arcellx Inc
16 Jun 22
Prospectus supplement with pricing info
5:10pm
of our proprietary platform technologies and achieve long-term growth and sustainability within the field of cell therapy. We believe our therapeutic
DRS
yo7osi8u55xn9g
13 Jun 22
Draft registration statement
6:05am
10-K
o97w8a au
24 Mar 22
Annual report
4:47pm
424B4
27ae10x3h7 8vgb6iig
7 Feb 22
Prospectus supplement with pricing info
5:12pm
S-1
EX-10.7
vhnt6ch1t4k0li8r
14 Jan 22
IPO registration
5:16pm
S-1
qpr9f
14 Jan 22
IPO registration
5:16pm
DRS/A
EX-10.7
0osx779kp
28 Dec 21
Draft registration statement (amended)
12:00am
DRS/A
ehm01fp
28 Dec 21
Draft registration statement (amended)
12:00am
DRS/A
o2j3qk9ydzvzv1
19 Nov 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.8
sg68hvsh
9 Jun 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next